FUNDOPLICATION CONVERSION IN ROUX-EN-Y GASTRIC BYPASS FOR CONTROL OF OBESITY AND GASTROESOPHAGEAL REFLUX: SYSTEMATIC REVIEW.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
obesity 4 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
obesity 984 of gastroesophageal reflux disease. Antireflux surgery has inadequate results when associated with obesity , due to migration and/or subsequent disruption of antireflux wrap. Gastric bypass, meanwhile, provides
obesity 3378 valve may occur[13]. On the other hand, gastric bypass (GB), a surgery widely used to treat morbid obesity , has excellent results in the control of gastroesophageal reflux[8]. In recent years, it has become
obesity 11646 to the number of patients, follow-up period and the fact that most individuals were carriers of mild obesity [7],[24]. GB has become the treatment of choice for GERD in this situation; its good results come from
obesity 14751 reported in all included articles; the majority of patients undergoing the new procedure had grade I obesity (some grade II); all authors pointed to the efficient excess weight loss after GB as an additional advantage[12],[13],[14],[17],[22],[25].CONCLUSIONDespite

You must be authorized to submit a review.